This content is current only at the time of printing. This document was printed on 24 July 2019. A current copy is located at https://apvma.gov.au/node/4161
You are here
APVMA cost recovery arrangements
The APVMA is funded by fees, charges and levies imposed on the industry it regulates. Chemical companies pay fees so the APVMA can evaluate registration proposals and renew product registrations, and a levy based on the wholesale sales of chemical products.
The current APVMA cost recovery arrangements were implemented in 2013.
In December 2011, we published a discussion paper that proposed further interim cost recovery arrangements for the APVMA in 2012–15. The paper focused on ensuring appropriate and sustainable revenue to enable efficient and effective administration of agvet chemical regulation and to minimise risks.
The December 2011 discussion paper also proposed a number of changes to the current arrangements for the recovery of costs associated with the assessment of compliance with Good Manufacturing Practice (GMP), which affects manufacturers of veterinary medicines in the Australian marketplace and registrants of imported veterinary products. Following consultation with a number of veterinary medicines industry groups we developed an alternative proposal for the recovery of costs associated with the assessment of compliance with GMP.
This alternative proposal was presented in a supplementary discussion paper on the cost recovery of compliance with GMP, published in May 2012. Submissions closed on 15 June 2012 and have been published online.
A Cost Recovery Impact Statement (CRIS) was then developed based on the two discussion papers and the consultation undertaken.
The then Minister for Agriculture, Fisheries and Forestry approved the CRIS in November 2012.
The cost recovery arrangements commenced on 1 July 2013 as per the cost recovery impact statement.
Implementation of the arrangements outlined in this CRIS was intended to coincide with the commencement date of 1 July 2013, as provided in the Agricultural and Veterinary Chemicals Legislation Amendment Bill 2012. Amendments to the Bill in the House of Representatives have since revised this commencement date to 1 July 2014.
Only those fees and charges revised independently of changes to the legislation commenced on 1 July 2013. Fees and charges associated with changes proposed in the Bill were deferred to coincide with the revised eventual commencement date of 1 July 2014, as outlined in the original CRIS and the amendment to the cost recovery impact statement.
An updated CRIS will be performed once relocation to Armidale is complete after 1 July 2019.
Deputy Chief Executive Officer
Legal, Corporate and Risk Management
PO Box 6182
Kingston ACT 2604
Phone: +61 2 6210 4701